Loperamide

Introduction Overview

Generic Name

loperamide

Brand Name

Diamode, Imodium, Maalox Anti-Diarrheal, Pepto Diarrhea Control, and others

Dosage Form

oral capsule, oral liquid, oral suspension, oral tablet, chewable tablet

Drug Class

Antidiarrheals

Pharmacokinetics

Absorption: Loperamide is rapidly absorbed from the gastrointestinal tract following oral administration. It undergoes extensive first-pass metabolism, which significantly reduces its systemic bioavailability. Despite high absorption, systemic concentrations are low because of this metabolism and the action of P-glycoprotein efflux pumps that limit central nervous system penetration. Food does not significantly affect the absorption of loperamide.

Distribution: After absorption, loperamide is widely distributed but mainly remains within the gastrointestinal tract due to its poor penetration of the blood-brain barrier. Plasma protein binding is high, ranging from 97% to 99%, primarily to alpha-1-acid glycoprotein. The volume of distribution is relatively large, reflecting distribution to tissues, but CNS exposure is minimal due to active efflux mechanisms.

Metabolism: Loperamide undergoes extensive hepatic metabolism primarily via cytochrome P450 enzymes, mainly CYP3A4 and CYP2C8. It is metabolized to inactive metabolites through oxidative processes. Because of its metabolism by these enzymes, inhibitors or inducers of CYP3A4 or CYP2C8 can affect plasma levels and efficacy of loperamide.

Elimination: The elimination half-life of loperamide is approximately 9 to 14 hours in adults. Excretion occurs mainly through the feces via biliary secretion of metabolites and unchanged drug, with minimal renal elimination (<1%). Due to enterohepatic recycling, loperamide’s therapeutic effects in the gut are prolonged despite low systemic concentrations. Impaired hepatic function can reduce clearance and increase systemic exposure.

Dosage Forms

Available Dosage Forms:
- Oral capsule (2 mg)
- Oral tablet (2 mg)
- Oral chewable tablet (2 mg)
- Oral liquid/suspension (variably concentrated solutions commonly at 1 mg/7.5 mL or similar)

Dosages for Adults and Adolescents:
- Initial dose: 4 mg PO after the first loose stool
- Maintenance dose: 2 mg PO after each subsequent unformed stool
- Maximum dose: Do not exceed 16 mg per day (eight 2 mg doses)
- Clinical improvement typically occurs within 48 hours

Specific Patient Populations:
- Children under 2 years: Loperamide is contraindicated
- Children 2 to 5 years: Use only after consulting a physician; dosing varies based on age and weight
- Patients with hepatic impairment: Use cautiously due to altered metabolism
- Patients with ileostomy: Dosing schedule may be regular; missed doses should be taken promptly unless close to next dose
- Dosage adjustments: None typically required for renal impairment due to minimal renal excretion

Clinical guidelines recommend against exceeding the maximum daily dose, and treatment duration should not exceed 2 days without medical advice to avoid risks of toxicity or worsening symptoms.

Mechanism Of Action

Loperamide is a synthetic opioid that acts primarily on the mu-opioid receptors located in the myenteric plexus of the large and small intestines. By binding these receptors, loperamide decreases the activity of the circular and longitudinal muscles of the intestinal wall, leading to a reduction in propulsive peristalsis and an increase in transit time of intestinal contents.

On a cellular level, activation of peripheral mu-opioid receptors by loperamide inhibits presynaptic release of acetylcholine and prostaglandins, which are mediators of gut motility and secretion. This leads to diminished smooth muscle contractility and reduced secretion of fluids into the intestinal lumen.

Because loperamide does not readily cross the blood-brain barrier due to the action of P-glycoprotein efflux transporters, it has minimal central opioid effects such as analgesia or euphoria, making it safe for over-the-counter use in anti-diarrheal therapy with a low risk of dependence.

Clinically, by slowing gastrointestinal motility, loperamide extends the time fecal matter stays in the intestines, allowing increased absorption of water and electrolytes, producing firmer stools and reduced frequency of defecation. Compared to other opioid antidiarrheals, loperamide’s peripheral restriction minimizes CNS side effects while effectively controlling diarrhea. This mechanism has been validated through clinical trials demonstrating symptom relief in acute and chronic diarrheal conditions.

Pharmacological Actions

Acting as a peripheral mu-opioid receptor agonist to reduce intestinal motility
Increasing intestinal transit time to enhance water and electrolyte absorption
Decreasing intestinal secretion by inhibiting neurotransmitter release
Reducing fecal volume and frequency of defecation in patients with diarrhea
Lacking significant central nervous system opioid effects due to limited blood-brain barrier penetration
Exhibiting anti-secretory properties that contribute to symptom relief in diarrhea
Modulating peristalsis by inhibiting acetylcholine-mediated smooth muscle contraction
Providing symptomatic relief in both acute and chronic diarrhea
Demonstrated to be effective in reducing stool frequency in patients with ileostomy
Minimal systemic absorption reduces risk of opioid-related systemic adverse effects
Does not influence underlying cause of diarrhea but manages symptoms effectively
Safe for over-the-counter use when taken as directed
Does not have analgesic or addictive properties when used appropriately
Not effective against diarrhea caused by invasive organisms or antibiotic-associated complications
Potential to cause constipation if overdosed, due to excessive slowing of gut motility

Therapeutic Or Clinical Uses

Management of acute nonspecific diarrhea in adults and children (with medical supervision)
Symptomatic treatment of chronic diarrhea associated with inflammatory bowel disease remission
Reduction of stool frequency and volume in patients with ileostomy
Control of travelers' diarrhea symptoms for symptomatic relief
Adjunct therapy in chronic diarrhea originating from irritable bowel syndrome
Palliative management of diarrhea in conditions such as short bowel syndrome
Temporary relief of diarrhea induced by enteral feeding
Reduction of stool output in patients with high-output ileostomy or colostomy
Use in healthcare settings to improve quality of life by controlling diarrhea-related symptoms
Off-label uses in certain cases of diarrhea not caused by invasive pathogens
Symptomatic management in diarrhea secondary to chemical or drug-induced causes (excluding infectious etiologies)
Limiting dehydration risk by controlling diarrheal symptoms in vulnerable populations
Used in combination with oral rehydration therapy to manage fluid and electrolyte balance
Safe for over-the-counter use for self-limited diarrheal illnesses in adults
Not recommended for use in diarrhea accompanied by fever, bloody stools, or caused by antibiotic-associated infections

Side Or Adverse Effects

Constipation, which may result from excessive slowing of intestinal motility
Dizziness and drowsiness, potentially impairing alertness
Nausea and abdominal cramping or discomfort
Dry mouth and occasional bloating
Rare allergic reactions including rash, itching, or angioedema
Serious cardiac adverse effects including arrhythmias, QT prolongation, especially with overdose or drug interactions
Potential for toxic megacolon in patients with inflammatory bowel disease if misused
Possible urinary retention and difficulty in micturition in sensitive individuals
Fatigue or malaise reported infrequently
Rare cases of central nervous system effects in cases of overdose despite limited CNS penetration
Skin reactions ranging from mild rash to severe systemic hypersensitivity are rare
Abdominal distension and bloating may occur with prolonged or excessive dosage
Risk of paralytic ileus if used in patients with obstructive bowel conditions
Overdose-associated symptoms include fainting and fast, irregular heartbeats
May cause worsening diarrhea or malignant symptoms if used in infectious diarrhea with high fever

Precautions

Do not use in patients with abdominal pain without diarrhea or with bloody/tarry stools
Avoid use in diarrhea associated with high fever or antibiotic-related colitis
Patients with known allergy to loperamide must not use this drug
Use caution and consult physician before use in children aged 2-5 years
Not recommended for children under 2 years of age due to safety concerns
Avoid use in patients with ulcerative colitis or suspected invasive bacterial enteritis
Consult healthcare provider if patient has liver impairment or cardiac arrhythmia history
Patients should avoid dehydration; maintain adequate fluid and electrolyte intake
Avoid concomitant use with other medications known to prolong QT interval or cause cardiac arrhythmias
Pregnant and breastfeeding women should use only under medical supervision
Instruct patients to stop therapy and seek medical advice if diarrhea persists beyond 48 hours
Do not combine with certain antimicrobials or antiretrovirals without professional guidance due to interaction risk
Monitor for signs of ileus or toxic megacolon particularly in inflammatory bowel disease cases
Avoid alcohol and CNS depressants concomitantly as they may increase drowsiness
Advise patients about proper dosing to prevent overdose and serious adverse cardiac events

Warnings

Do not use if patient has ulcerative colitis, bloody or tarry stools, or diarrhea with high fever
Loperamide overdose can cause serious heart problems including arrhythmias and death
Concomitant use with drugs causing QT prolongation increases risk of fatal cardiac arrhythmias
Avoid use in children younger than 2 years due to risk of serious adverse effects
Children aged 2 to 5 years require physician consultation before use
Discontinue use and seek emergency care if signs of allergic reaction or severe skin rash occur
Stop treatment if diarrhea worsens or persists beyond 2 days to avoid complications
Patients with cardiac rhythm disorders should use loperamide cautiously and under medical supervision
Avoid using for diarrhea caused by bacterial infections to prevent masking serious conditions
Avoid tonic water consumption during treatment due to potential for serious cardiac interactions
Loperamide should not be used to treat diarrhea caused by Clostridium difficile without medical approval
Risk of respiratory depression and CNS toxicity is low but may increase with overdose or abuse
Not recommended for use in diarrheal illness complicated by fever or invasive pathogens
Potential for misuse and abuse at higher-than-recommended doses; use strictly as directed
Use with caution in patients with hepatic impairment due to altered pharmacokinetics

Contraindication

Known hypersensitivity or allergy to loperamide or any formulation components
Children under 2 years of age due to risk of serious adverse events
Diarrhea with abdominal pain without presence of diarrhea
Diarrhea accompanied by bloody, black, or tarry stools
Diarrhea with high fever indicating possible invasive infection
Diarrhea caused by bacterial enterocolitis such as Salmonella, Shigella, or Campylobacter
Patients with ulcerative colitis due to risk of toxic megacolon and worsening condition
Known or suspected bacterial enteritis or antibiotic-associated colitis, particularly Clostridium difficile infection
Intestinal obstruction or conditions causing paralytic ileus
Severe hepatic impairment due to altered metabolism and potential toxicity
Patients with known cardiac conduction disturbances without physician approval

Drug Interactions

Concomitant use with CYP3A4 inhibitors (e.g. ketoconazole, itraconazole) may increase loperamide plasma levels and risk of toxicity
Concurrent use with CYP2C8 inhibitors can similarly raise systemic exposure
Drugs that prolong QT interval (e.g., certain antiarrhythmics, antipsychotics, macrolides) increase risk of serious cardiac arrhythmias when combined with loperamide
P-glycoprotein inhibitors (e.g., quinidine, ritonavir) can increase CNS penetration and toxicity risk
CNS depressants may exacerbate drowsiness or dizziness side effects
Anticholinergic drugs may have additive effects on gut motility and secretions
Co-administration with opioids could enhance opioid-related adverse events
Avoid use with tonic water due to increased risk of adverse cardiac events
Certain antidepressants and antipsychotics can act synergistically to prolong QT interval with loperamide
Interactions with HIV protease inhibitors and antimalarials may impact metabolism and cardiac safety
Herbal supplements affecting CYP enzymes or P-glycoprotein may alter drug levels
Concurrent use with anticoagulants requires caution due to risk of bleeding if diarrhea is masked
Potential interactions with methotrexate necessitate medical monitoring
Avoid simultaneous use with other antidiarrheals to prevent severe constipation or toxicity
Inform healthcare provider of all medications including over-the-counter vitamins and herbal products prior to loperamide administration

Preparations Of The Drug

Imodium A-D: commonly available over-the-counter oral tablets and capsules (2 mg)
Diamode: oral capsules and liquid suspension formulations for antidiarrheal use
Maalox Anti-Diarrheal: combined preparations containing loperamide for symptomatic relief
Pepto Diarrhea Control: contains loperamide in oral tablet form
Imotil and Kao-Paverin: branded oral liquid and tablets available in some markets
Anti-Diarrheal Tablet: FDA-approved generic loperamide tablets
Oral suspension preparations provided with dosing syringes for pediatric and adult use
Up and Up Anti-Diarrheal Solution: generic liquid formulations
Combination products with antacids or other gastrointestinal agents usually available OTC
Chewable tablets designed for ease of administration in patients unable to swallow capsules
Standardized 2 mg dosing units for precise and flexible dosing
FDA-approved prescription formulations for higher dosing regimens in chronic diarrhea
Bulk manufacturing in both prescription and over-the-counter categories
Formulations stored at room temperature, protected from moisture and freezing
Several generic and branded products available worldwide providing accessible treatment options